Testing the ETM: Examination and Comparison of Different Methods
NCT05946031 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 87
Last updated 2025-10-02
Summary
This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.
Conditions
- Cigarette Smoking
Interventions
- DRUG
-
Reat ETM
Exclusive cigarette smokers will be recruited and will be exposed to the real ETM condition in which tobacco purchases are real and they receive products from one randomly selected trial.
- DRUG
-
Hypothetical ETM
Exclusive cigarette smokers will be recruited and will be exposed to the hypothetical ETM condition in which tobacco purchases are hypothetical and they don't receive any products.
Sponsors & Collaborators
-
Virginia Polytechnic Institute and State University
lead OTHER
Principal Investigators
-
Roberta Freitas-Lemos, Ph.D. · Fralin Biomedical Research Institute at VTC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-28
- Primary Completion
- 2025-08-14
- Completion
- 2025-08-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
NCT00717093 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Nicotine Agents for Smoking Cessation
NCT00108537 ·Status: COMPLETED ·Phase: PHASE3
-
Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace
NCT05110872 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking
NCT00635401 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
NCT00371813 ·Status: COMPLETED ·Phase: PHASE3
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00141206 ·Status: COMPLETED ·Phase: PHASE3
-
COMET Study 1: Filter Ventilated Cigarette Substitution in the ETM
NCT03306173 ·Status: COMPLETED ·Phase: NA
-
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781 ·Status: TERMINATED ·Phase: PHASE4
-
Effectiveness of Varenicline: Testing Individual Differences
NCT01228175 ·Status: COMPLETED ·Phase: PHASE4
-
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
NCT00527150 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes
NCT00622752 ·Status: COMPLETED ·Phase: PHASE2
-
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
NCT04634071 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetics of Nicotine Addiction Treatment
NCT01314001 ·Status: COMPLETED ·Phase: PHASE3
-
Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy
NCT01980550 ·Status: COMPLETED ·Phase: PHASE4
-
Methods Project 4: Clinical Trial - Amended
NCT03111537 ·Status: COMPLETED ·Phase: NA
-
Treating Smokeless Tobacco Use in Rural Veterans
NCT02994082 ·Status: UNKNOWN ·Phase: NA
-
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00143364 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
NCT00419731 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation
NCT02342795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
Varenicline For Smokers In Recovery From Alcohol Dependence
NCT01092702 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients
NCT03272295 ·Status: COMPLETED ·Phase: NA
-
Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)
NCT02551692 ·Status: COMPLETED ·Phase: NA
-
Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability: Study 7
NCT03496922 ·Status: COMPLETED ·Phase: NA